Literature DB >> 6817677

Inactivation of human bronchial mucosal proteinase inhibitor by Pseudomonas aeruginosa elastase.

D A Johnson, B Carter-Hamm, W M Dralle.   

Abstract

Human bronchial mucus contains an acid-stable proteinase inhibitor called bronchial mucous inhibitor (BMI) that apparently protects the upper airways from proteolysis by polymorphonuclear leukocyte (PMN) elastase and cathepsin G, and infections of Pseudomonas aeruginosa, which also produces an elastase, can result in considerable lung damage. The possible role of BMI in protecting the lung from proteolytic attack in the presence of P. aeruginosa elastase (a zinc metalloprotease) was investigated. The BMI not only failed to inhibit P. aeruginosa elastase but the ability of BMI to inhibit PMN elastase and cathepsin G was rapidly lost in the presence of the bacterial elastase. The P. aeruginosa elastase also freed active PMN elastase from complexes with BMI, resulting in elastin digestion by both enzymes. The proteolysis of lung tissue observed with P. aeruginosa infections may be caused by a combination of bacterial and PMN proteases. Elastase and cathepsin G released from leukocytes, attracted to P. aeruginosa infection sites, would be free to attack the bronchial tissues after BMI inactivation by P. aeruginosa elastase, adding to the damage caused by the bacterial protease(s).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6817677     DOI: 10.1164/arrd.1982.126.6.1070

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  26 in total

Review 1.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

2.  Disruption of respiratory cilia by proteases including those of Pseudomonas aeruginosa.

Authors:  S T Hingley; A T Hastie; F Kueppers; M L Higgins
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

Review 3.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

4.  Structural gene and complete amino acid sequence of Pseudomonas aeruginosa IFO 3455 elastase.

Authors:  J Fukushima; S Yamamoto; K Morihara; Y Atsumi; H Takeuchi; S Kawamoto; K Okuda
Journal:  J Bacteriol       Date:  1989-03       Impact factor: 3.490

5.  Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.

Authors:  George R A Cathcart; Derek Quinn; Brett Greer; Pat Harriott; John F Lynas; Brendan F Gilmore; Brian Walker
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

6.  A novel locust (Schistocerca gregaria) serine protease inhibitor with a high affinity for neutrophil elastase.

Authors:  Michèle Brillard-Bourdet; Ahmed Hamdaoui; Eric Hajjar; Christian Boudier; Nathalie Reuter; Laurence Ehret-Sabatier; Joseph G Bieth; Francis Gauthier
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

Review 7.  The role of inflammation in the pathophysiology of CF lung disease.

Authors:  James F Chmiel; Melvin Berger; Michael W Konstan
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

8.  Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.

Authors:  Sinéad Weldon; Paul McNally; Noel G McElvaney; J Stuart Elborn; Danny F McAuley; Julien Wartelle; Abderrazzaq Belaaouaj; Rodney L Levine; Clifford C Taggart
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 9.  New perspectives in understanding and management of the respiratory disease in cystic fibrosis.

Authors:  S Suter
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

10.  Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases.

Authors:  C E Smith; D A Johnson
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.